Phenylketonuria: questioning the gospel

References

• De Waal F. The Ape and the Sushi Master. Basic Books, NY, USA 85–86 (2001).
   Google Scholar
• Quoted by MacGillivray TE, Vlahares GJ. Minimally invasive bypass surgery. N. Engl. J. Med.347(260), 2167–2168 (2002).
   Google Scholar
• Shekelle PG, Ortiz E, Rhodes S et al. Validity of the agency for healthcare research and quality clinical practice guidelines: how quickly do guidelines become outdated? JAMA286(12), 1461–1467 (2001).
   PubMed Web of Science ®Google Scholar
• Fölling A. Uber ausscheidung von phenbrenztraubensaure in den harn als stoffwechselanomalie in verbindung mit imbezillitat. Hoppe-Seyler’s Z. Physiol. Chem.227, 169–176 (1934).
   Google Scholar
• Bickel H, Gerrard J, Hickmans EM. The influence of phenylalanine intake on the chemistry and behavior of a phenylketonuria child. Acta Paediatr.43, 64–77 (1954).
   Google Scholar
• Guthrie R, Susi A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics32, 338–343 (1963).
   PubMed Web of Science ®Google Scholar
• Guttler F. Hyperphenylalaninemia: diagnosis and classification of the various types of phenylalanine hydroxylase deficiency in childhood. Acta Paediatr. Scand. (Suppl. 280), 44–47 (1980).
   Google Scholar
• Rutherford P, Poustie V, Rutherford P. Protein substitute for children and adults with phenylketonuria. Cochrane Database Syst. Rev.19(4), CD004731 (2005).
   Google Scholar
• Bodkin JR. Research for newborn screening: developing a national framework. Pediatrics116(4), 862–871 (2005).
   Google Scholar
• Smith ML, Saltzman J, Klim P, Hanley WB, Clarke JTR. Neuropsychological, academic and behavioral function in mild hyperphenylananinemia. Am. J. Ment. Retard.105(2), 69–80 (2000).
   Google Scholar
• Levy H, Waisbren SE, Guttler F et al. Pregnancy experiences in the woman with mild hyperphenylalaninemia. Pediatrics112(6), 1548–1552 (2003).
   PubMed Web of Science ®Google Scholar
• Matalon R, Michals K, Blau N, Rouse B. Hyperphenylananinemia due to inherited deficiencies of tetrahydrobiopterin. Adv. Pediatr.36, 67–90 (1989).
   Google Scholar
• Levy HL, Ghavami M. Maternal phenylketonuria: a metabolic teratogen. Teratology53, 176–184 (1996).
   PubMedGoogle Scholar
• National Institutes of Health Consensus Development Conference Statement. Phenylketonuria. National Institutes of Health Consensus Development Panel. Pediatrics108, 972–982 (2001).
   PubMed Web of Science ®Google Scholar
• Jervis GA. Phenylpyruvic pligophrenia (phenylketonuria). Res. Publ. Assoc. Res. Nerv. Ment. Dis.33, 259–282 (1954).
   Google Scholar
• Knox WE. An evaluation of the treatment of phenylketonuria with diets low in phenylalanine. Pediatrics26, 1–11 (1960).
   PubMed Web of Science ®Google Scholar
• Paine RS. The variability in manifestations of untreated patients with PKU. Pediatrics20, 290–297 (1957).
   PubMedGoogle Scholar
• Partington MW. Variations in intelligence in phenylketonuria. CMAJ86, 736–743 (1962).
   PubMed Web of Science ®Google Scholar
• Pitt D. The natural history of untreated phenylketonuria. Med. J. Aust.1, 378–383 (1971).
   PubMed Web of Science ®Google Scholar
• McKusick VA. Phenylketonuria (PKU) – 261600. In: Mendelian Inheritance in Man (12th Edition). The Johns Hopkins University Press. Baltimore, MD, USA (1998).
   Google Scholar
• Levy HL, Karolkewicz V, Houghton SA, MacCready RA. Screening the ‘normal’ population in Massachusetts for phenylketonuria. N. Engl. J. Med.282, 455–458 (1970).
   Google Scholar
• Hanley WB, Prenatal testing for maternal phenylketonuria (PKU). Int. Pediatr.9(Suppl. 1), 33–39 (1994).
   Google Scholar
• Machill VG, Seidlitz G, Grimm U, Knapp A. Zur haufigkeit der phenylketonurie mit narmaler intelligenz. Z. Klin. Med.45, 182–183 (1990).
   Google Scholar
• Berman JL, Cunningham GC, Day RW et al. Causes for high phenylalanine with normal tyrosine in newborn screening programs. Am. J. Dis. Child.117, 54–65 (1969).
   PubMedGoogle Scholar
• Koch R, Acosta P, Shaw KNF et al. In: Phenylketonuria and Some Other Inborn Errors of Metabolism. Bickle H, Hudson FP, Woolf LI, Acosta PB (Eds). GT Verlag, Stuttgart, Germany 20–25 (1971).
   Google Scholar
• Levy HL, Waisbren SE. Effects of untreated maternal phenylketonuria and hyperphenylalaninemia on the fetus. N. Engl. J. Med.309, 1269–1274 (1983).
   PubMed Web of Science ®Google Scholar
• Waisbren SE, Schnell RR, Levy HL. Intelligence and personality characteristics in adults with untreated atypical phenylketonuria and mild hyperphenylalaninemia. J. Pediatr.105, 955–958 (1984).
   PubMed Web of Science ®Google Scholar
• Hanley WB, Platt LD, Bachman RP et al. Undiagnosed maternal phenylketonuria: the need for prenatal selective screening or case finding. Am. J. Obstet. Gynecol.180, 986–994 (1999).
   PubMed Web of Science ®Google Scholar
• Weglage J, Moller HE, Wiederman D, Cipic-Schmidt S, Zschocke J, Ulrich K. In vivo NMR spectroscopy in patients with phenylketonuria: clinical significance of interindividual differences in brain phenylalanine concentrations. J. Inherit. Metab. Dis.221, 81–82 (1998).
   Google Scholar
• Moats RA, Koch R, Moseley K et al. Brain phenylalanine concentration in the management of adults with phenylketonuria. J. Inherit. Metab. Dis.23, 7–14 (2000).
   PubMedGoogle Scholar
• Bik-Multanowski M, Pietrzyk JJ. Brain phenylalanine measurement in patients with phenylketonuria: a serious diagnostic method or just reading tea leaves? Mol. Genet. Metab.91(3), 297–298 (2007).
   Google Scholar
• Medical Research Council Working Party on Phenylketonuria. Recommendations on the dietary management of phenylketonuria. Arch. Dis. Child.68, 426–427 (1993).
   PubMed Web of Science ®Google Scholar
• Burgard P, Bremer HJ, Buhrdel P et al. Rational for the German recommendations for phenylalanine level control in phenylketonuria. Eur. J. Pediatr.158, 46–54 (1997).
   Google Scholar
• de Baulny HO, Abadie V, Feillet F, de Parscau L. Management of phenylketonuria and hyperphenylalaninemia. J. Nutr.137(6 Suppl. 1), S1561–S1563 (2007).
   Google Scholar
• Smith I, Beasley MG, Ades AE. Intelligence and quality of dietary treatment in phenylketonuria. Arch. Dis. Child.65, 472–478 (1990).
   PubMed Web of Science ®Google Scholar
• Smith I, Beasley MG, Ades AE. Effect on intelligence of relaxing the low phenylalanine diet in phenylketonuria. Arch. Dis. Child.66, 311–316 (1991).
   PubMed Web of Science ®Google Scholar
• Weglage J, Ullrich K, Pietsch M, Funders B, Guttler F, Harmes E. Intellectual, neurological and neuropsychological outcome in untreated subjects with nonphenylketonuria hyperphenylaninemia. German collaborative study on phenylketonuria. Pediatr. Res.42(3), 378–384 (1997).
   Google Scholar
• Costello PM, Beasley MG, Tillotson SL, Smith I. Intelligence in mild atypical phenylketonuria. Eur. J. Pediatr.153, 260–263 (1994).
   Google Scholar
• McChesney R, Habermann J, Greengard O. Phenylalanine uptake in neonatal and infant rat brain. Biol. Neonate54, 275–284 (1988).
   Google Scholar
• Walter JH, White FJ, Hall SK et al. How practical are recommendations for dietary control in phenylketonuria. Lancet360, 55–57 (2002).
   PubMed Web of Science ®Google Scholar
• Meli C, Bianca S. Dietary control of phenylketonuria. Lancet360, 2075–2076 (2002).
   Web of Science ®Google Scholar
• Mundy H, Liburn M, Cousins A, Lee P. Dietary control of phenylketonuria. Lancet360, 2076 (2002).
   Google Scholar
• Beasley MG, Costello PM, Smith I. Outcome of treatment in young adults with phenylketonuria detected by routine neonatal screening between 1964 and 1971. QJM87, 155–160 (1993).
   Google Scholar
• Brumm VL, Azen C, Moats RA et al. Neuropsychological outcome of subjects participating in the PKU adult collaborative study: a preliminary review. J. Inherit. Metab. Dis.27(5), 549–566 (2004).
   PubMed Web of Science ®Google Scholar
• Koch R, Fishler K, Azen C, Guldberg P, Guttler F. The relationship of genotype to phenotype in phenylalanine hydroxylase deficiency. Biochem. Mol. Med.60, 92–101 (1997).
   Google Scholar
• Schmidt E, Rupp A, Burgard P et al. Sustained attention in adult phenylketonuria: the influence of concurrent phenylalanine blood-level. J. Clin. Exp. Neuropsychol.16, 681–688 (1994).
   PubMed Web of Science ®Google Scholar
• Thompson AJ, Smith I, Brenton D et al. Neurological deterioration in young adults with phenylketonuria. Lancet336, 602–605 (1990).
   PubMed Web of Science ®Google Scholar
• Weglage J, Oberwittler C, Marquardt T et al. Neurological deterioration in adult phenylketonuria. J. Inherit. Metab. Dis.23, 83–84 (2000).
   Google Scholar
• Ishimaru K, Tamasawa N, Baba M, Matsunaga M, Takebe K. Phenylketonuria with adult-onset neurological manifestations. Rinsho Shinkeigaku33, 961–965 (1993).
   PubMedGoogle Scholar
• Kasim S, Moo LR, Zschocke J, Jinnah HA. Phenylketonuria presenting in adulthood as progressive spastic paraparesis with dementia. J. Neurol. Neurosurg. Psychiatr.71, 795–797 (2001).
   PubMed Web of Science ®Google Scholar
• Anderson AE, Avins L. Lowering brain phenylalanine levels by giving other large neutral amino acids. Arch. Neurol.33, 684–686 (1976).
   Google Scholar
• Schindeler S, Ghosh-Jerath S, Thompson S et al. The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study. Mol. Genet. Metab.91, 48–54 (2007).
   PubMed Web of Science ®Google Scholar
• Matalon R, Michals-Matalon K, Bhatia G et al. Double blind placebo control trial of large neutral amino acids in treatment of PKU: effect on blood phenylalanine. J. Inherit. Metab. Dis.30, 153–158 (2007).
   PubMed Web of Science ®Google Scholar
• Sarkissian CN, Shao Z, Blain F et al. A different approach to treatment of phenylketonuria: phenylalanine degradation with recombinant phenylalanine ammonia lyase. Proc. Natl Acad. Sci. USA96, 2339–2344 (1999).
   PubMed Web of Science ®Google Scholar
• MacDonald MJ, D’Cunha GB. A modern view of phenylalanine ammonia lyase. Biochem. Cell Biol.85(3), 273–282 (2007).
   PubMed Web of Science ®Google Scholar
• Ikeda K, Schiltz E, Fuji T et al. Phenylalanine ammonia lyase modified with polyethylene glycol: potential therapeutic agent for phenylketonuria. Amino Acids29(3), 283–287 (2005).
   Google Scholar
• Gamez A, Wang L, Sarkissian CN et al. Structure-based epitope and PEGylation sites mapping of phenylalanine ammonia-lyase for enzyme substitution treatment of phenylketonuria. Mol. Genet. Metab.91(4), 325–334 (2007).
   PubMed Web of Science ®Google Scholar
• Kure S, Hou D-C, Ohura T et al. Tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency. J. Pediatr.135, 375–378 (1999).
   PubMed Web of Science ®Google Scholar
• Fiege B, Blau N. Assessment of tetrahydrobiopterin (BH4) responsiveness in phenylketonuria. J. Pediatr.150, 627–630 (2007).
   PubMed Web of Science ®Google Scholar
• Muntau AC, Roschinger W, Habich M et al. Tetrahydrobiopterin as an alternative treatment for mild phenylketonuria. N. Engl. J. Med.347, 2112–2132 (2002).
   Google Scholar
• Michals-Matalon K, Bhatia G, Guttler F, Tyring SK, Matalon R. Response of phenylketonuria to tetrahydrobiopterin. J. Nutr.137(6 Suppl. 1), S1564–S1567 (2007).
   PubMed Web of Science ®Google Scholar
• Yang L, Zhang Z, Ye J et al. Clinical study of tetrahydrobiopterin responsive phenylalanine hydroxylase deficiency in southern and northern Chinese patients. Zhonghua Yi Xue Yi Chuan Xue Za Zhi24(3), 310–313 (2007).
   Google Scholar
• Yildirim S, Tokatli A, Yilmaz E, Coskun T. Assessment of tetrahdrobiopterin responsiveness in Turkish hyperphenylalaninemic patients. Turk. J. Pediatr.49(1), 1–6 (2007).
   Google Scholar
• Levy HL, Milanowski A, Chakrapani A et al. Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6H-BH4) for reduction of phenylalanine levels in patients with phenylketonuria: a Phase III randomized placebo-controlled study. Lancet370(9586), 504–510 (2007).
   PubMed Web of Science ®Google Scholar
• Weglage J, Grenzebach M, von Teeffelen-Heithoff A. Tetrahydrobiopterin responsiveness in a large series of phenylketonuria patients. J. Inherit. Metab. Dis.25, 321–322 (2002).
   PubMed Web of Science ®Google Scholar
• Fang B, Eisensmith RC, Li XHC et al. Gene therapy for phenylketonuria: phenotypic correction in genetically deficient mouse by adenovirus mediated hepatic gene transfer. Gene Ther.1, 247–254 (1994).
   PubMed Web of Science ®Google Scholar
• Eavri R, Lorberboum-Galski H. A novel approach for enzyme replacement therapy: the use of phenylalanine hydroxylase-based fusion proteins for the treatment of phenylketonuria. J. Biochem.282(32), 23402–23409 (2007).
   Google Scholar
• Greeves LG, Carson DJ, Magee A, Patterson CC. Fractures and phenylketonuria. Acta Pediatr.86, 242–244 (1997).
   Google Scholar
• Perez-Duenas B, Cambra FJ, Vilaseca MA, Lambruschini N, Campistol J, Camacho JA. New approach to osteopenia in phenylketonuric patients. Acta Pediatr.91, 899–904 (2002).
   Google Scholar
• Ambroszkiewicz J, Gajewski J, Laskowska-Klita T. A study in bone turnover markers in pre-pubertal children with phenylketonuria. Eur. J. Pediatr.163, 177–178 (2004).
   Google Scholar
• Al-Qadreh A, Schulpis KH, Athanasopoulou H, Mengreli C, Skarpalezou A, Voskaki I. Bone mineral status in children with phenylketonuria under treatment. Acta Paediatr.87, 1162–1166 (1998).
   Google Scholar
• Modan-Moses D, Vered I, Schwartz G et al. Peak bone mass in patients with phenylketonuria. J. Inherit. Metab. Dis.30(3), 202–208 (2007).
   PubMed Web of Science ®Google Scholar
• Robinson M, White FJ, Cleary MA, Wraith E, Lam WK, Walter JH. Increased risk of vitamin B12 deficiency in patients with phenylketonuria on an unrestricted or relaxed diet. J. Pediatr.138, 545–547 (2000).
   Google Scholar
• Hanley WB, Feigenbaum ASJ, Clarke JTR, Schoonheyt WE, Austin VJ. Vitamin B12 deficiency in adolescents and young adults with phenylketonuria. Eur. J. Pediatr.155(Suppl. 1), S145–S147 (1996).
   PubMed Web of Science ®Google Scholar
• Nygard O, Vollset SE, Refsum H et al. Total plasma homocysteine and cardiovascular risk factors. JAMA274, 1526–1533 (1995).
   PubMed Web of Science ®Google Scholar
• Galli C, Agostoni C, Mosconi C, Riva E, Salari PC, Giovannini M. Reduced plasma C-20 and C-22 polyunsaturated fatty acids in children with phenylketonuria during dietary intervention. J. Pediatr.119, 562–567 (1991).
   Google Scholar
• Sanjurjo P, Pertreagudo L, Rodrigues Soriano J, Vilaseca A, Campistol J. Polyunsaturated fatty acid status in patients with phenylketonuria. J. Inherit. Metab. Dis.17, 704–709 (1994).
   Google Scholar
• Beblo S, Reinhardt H, Muntau AC, Mueller-Felber W, Roscher AA, Koletzko B. Fish oil supplementation improves visual evoked potentials in children with phenylketonuria. Neurology57, 1488–1491 (2001).
   Google Scholar
• Beblo S, Reinhardt H, Demmelmair H, Muntau AC, Koletzko B. Effects of fish oil supplementation on fatty acid status, coordination, and fine motor skills in children with phenylketonuria. J. Pediatr.150, 479–484 (2007).
   PubMed Web of Science ®Google Scholar
• Agostini C, Harvie A, McCulloch DL et al. A randomized trial of long-chain polyunsaturated fatty acid supplementation in infants with phenylketonuria. Dev. Med. Child. Neurol.48, 207–212 (2006).
   Google Scholar
• Dobbelaere D, Michaud L, Debrabander A et al. Evaluation of nutritional status and pathophysiology of growth retardation in patients with phenylketonuria. J. Inherit. Metab. Dis.26(1), 1–11 (2003).
   Google Scholar
• Acosta PB, Yanicelli S, Singh R et al. Nutrient intakes and physical growth of children with phenylketonuria undergoing nutrition therapy. J. Am. Diet. Assoc.103(9), 1167–1173 (2003).
   PubMedGoogle Scholar
• van Spronsen FJ, Verkerk PH, van Houten M et al. Does impaired growth of PKU patients correlate with strictness of dietary treatment? Acta Paediatr.86, 816–818 (1997).
   Google Scholar
• Hoeksma M, van Rijn M, Verkerk PH et al. The intake of total protein, natural protein and protein substitute and growth of height and head circumference in Dutch infants with phenylketonuria. J. Inherit. Metab. Dis.28, 845–854 (2005).
   Google Scholar
• Drogari E, Beasley M, Smith I, Lloyd JK. Timing of strict diet in relation to fetal damage in maternal phenylketonuria. Lancet2(8565), 927–930 (1987).
   Google Scholar
• Koch R, Hanley W, Levy H et al. The maternal PKU international study. Pediatrics112, 1523–1529 (2003).
   PubMed Web of Science ®Google Scholar